Diamedix
Integrated laboratory diagnostics, reagents, and equipment distributor.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
| EUR | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (12 %) | 16 % | 11 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 17 % | 11 % | 8 % | 14 % |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Diamedix Impex SA is a Romanian-based distributor of in-vitro diagnostic (IVD) solutions, serving laboratories, clinics, and hospitals. Founded in 1996 by Vasileios Chrelias, the company has become one of the largest independent medical equipment distributors in Romania. Diamedix is headquartered in Bucharest and operates as a wholesaler of medical equipment and supplies.
The company's business model is focused on the distribution of a wide range of products for clinical laboratories, including integrated instruments, reagent systems, and consumables for detecting autoimmune and infectious diseases. Its portfolio covers biochemistry, immunology, hematology, microbiology, and point-of-care testing. Diamedix also provides specialized equipment for medical imaging, such as ultrasound and mammography devices, and offers solutions for food safety testing. The company generates a significant portion of its revenue, approximately 90%, from supplying instruments to laboratories and the subsequent provision of tests.
Throughout its history, Diamedix has undergone several ownership changes. In March 2009, it was acquired by the Spanish private equity group GED Capital for $15.2 million. More recently, in March 2025, the EMMA Capital Group, a Czech-based private investment holding, acquired a majority stake in the company, with the founder, Vasileios Chrelias, retaining a 20% stake and continuing to lead the company through a transition period. This acquisition is part of EMMA Capital's strategy to strengthen its position in the medical equipment distribution sector in Southeastern Europe. The company has also expanded its geographical footprint, with subsidiaries in Kyiv, Chisinau, and Sofia.
Keywords: medical equipment distributor, in-vitro diagnostics, laboratory equipment, reagents, immunoassay systems, clinical laboratory, medical imaging, autoimmune diseases, infectious diseases, biochemistry, hematology, microbiology, point-of-care testing, food safety testing, molecular diagnostics, ELISA kits, diagnostic products, healthcare sector, medical supplies, Romanian healthcare